Literature DB >> 32274985

COVID-19: The Need for Immunoprevention at Industrial Scale.

Scott B Halstead1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32274985      PMCID: PMC7253134          DOI: 10.4269/ajtmh.20-0239

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  10 in total

Review 1.  Post-exposure passive immunisation for preventing measles.

Authors:  Megan K Young; Graeme R Nimmo; Allan W Cripps; Mark A Jones
Journal:  Cochrane Database Syst Rev       Date:  2014-04-01

2.  Use of Concentrated Human Serum gamma-Globulin in the Prevention and Attenuation of Measles.

Authors:  C A Janeway
Journal:  Bull N Y Acad Med       Date:  1945-04

Review 3.  Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).

Authors:  Balamurugan Shanmugaraj; Konlavat Siriwattananon; Kittikhun Wangkanont; Waranyoo Phoolcharoen
Journal:  Asian Pac J Allergy Immunol       Date:  2020-03       Impact factor: 2.310

4.  The convalescent sera option for containing COVID-19.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 5.  Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.

Authors:  Eakachai Prompetchara; Chutitorn Ketloy; Tanapat Palaga
Journal:  Asian Pac J Allergy Immunol       Date:  2020-03       Impact factor: 2.310

6.  Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951-1953.

Authors:  Charles R Rinaldo
Journal:  Am J Public Health       Date:  2005-05       Impact factor: 9.308

7.  Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.

Authors:  Emmie de Wit; Friederike Feldmann; Jacqueline Cronin; Robert Jordan; Atsushi Okumura; Tina Thomas; Dana Scott; Tomas Cihlar; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-13       Impact factor: 11.205

8.  Infectious hepatitis: current status of prevention with gamma globulin.

Authors:  S KRUGMAN; R WARD
Journal:  Yale J Biol Med       Date:  1961 Dec-1962 Feb

Review 9.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226

10.  Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.

Authors:  Yushun Wan; Jian Shang; Shihui Sun; Wanbo Tai; Jing Chen; Qibin Geng; Lei He; Yuehong Chen; Jianming Wu; Zhengli Shi; Yusen Zhou; Lanying Du; Fang Li
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.